AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01379-06v1
51/9/3122    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuo, C.-F.
Right arrow Articles by Tsao, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuo, C.-F.
Right arrow Articles by Tsao, N.
Antimicrobial Agents and Chemotherapy, September 2007, p. 3122-3130, Vol. 51, No. 9
0066-4804/07/$08.00+0     doi:10.1128/AAC.01379-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Concanavalin A Protects Mice from a Lethal Inoculation of Intragastric Klebsiella pneumoniae and Reduces the Induced Liver Damage{triangledown}

Chih-Feng Kuo,1 Ya-Hui Wang,2 Huan-Yao Lei,2 Chiou-Huey Wang,3 and Nina Tsao4*

Departments of Nursing,1 Biological Science and Technology, I-Shou University, Kaohsiung County,4 Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan,2 Department of Clinical Pathology, E-DA Hospital, Kaohsiung County, Taiwan3

Received 3 November 2006/ Returned for modification 8 December 2006/ Accepted 22 June 2007

Intragastric inoculation of Klebsiella pneumoniae can cause invasive diseases, including necrosis of liver tissues and bacteremia. The effect of concanavalin A (ConA) on K. pneumoniae was tested. Pretreatment with ConA was able to protect mice from K. pneumoniae infection in an intragastric model. K. pneumoniae-induced mouse death and liver injury such as liver necrosis, as well as blood levels of aspartate aminotransferase and alanine aminotransferase, were inhibited in a dose-dependent manner by ConA. ConA administered intravenously as late as 24 h after K. pneumoniae inoculation was still protective. In an in vitro assay, ConA was able to bind K. pneumoniae cells directly and further agglutinate them but had no effect on their in vitro growth. Surveys of bacterial counts of ConA-treated mice revealed that the bacteria were eliminated effectively in both blood and liver tissues. Furthermore, the bactericidal activity of macrophages against K. pneumoniae was also enhanced in a dose-dependent manner by ConA in an in vitro culture. These data suggest that ConA is a potentially therapeutic agent for K. pneumoniae-induced liver infection.

* Corresponding author. Mailing address: Department of Biological Science and Technology, I-Shou University, Kaohsiung County, Taiwan. Phone: 886-7-6577711, ext. 3465. Fax: 886-7-2252051. E-mail: ninatsao{at}isu.edu.tw

{triangledown} Published ahead of print on 2 July 2007.

Antimicrobial Agents and Chemotherapy, September 2007, p. 3122-3130, Vol. 51, No. 9
0066-4804/07/$08.00+0     doi:10.1128/AAC.01379-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.